Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Jingyun Li, Menglin Wang, Xu Zhang, Xueyan Wang et autres
cn, us (code pays fourni par la source)
0 citations
The Lancet Regional Health - Western Pacific